AMMF’s “inspirational meeting”

AMMF's Information Day at Imperial College London, 10 May 2016 Malcolm Robinson, CC survivor and longstanding AMMF supporter, summed up the thoughts of many of those who attended AMMF's Information Day on 10 May at Imperial College London: “A wonderful opportunity to find out just how all the AMMF fundraising efforts of our supporters is invested in medical experts of the highest quality and dedicatio...

Read More

The Two Toms in Thailand

Two Imperial College London 'medical students to be', Tom Hughes and Tom O'Connor, have taken on an elective period of research and study into cholangiocarcinoma in Kohn Kaen, Thailand, and are sharing their experiences with AMMF.             The Two Toms blogged especially for the inaugural World Cholangiocarcinoma Day on 17 February 2016 - to read...

Read More

AMMF in Thailand 2016

The incidence of cholangiocarcinoma is increasing, not only in the UK but throughout the world.  It is certainly a global problem, but Thailand has the world's highest incidence of this disease, with the Isaan Province in the north east of the country being the epicentre. Following the 3-day international cholangiocarcinoma workshop in Khon Kaen in north east Thailand in 2014, which AMMF attended, and w...

Read More

AMMF launches Discussion Forum

After many requests, AMMF has now launched a Discussion Forum on its new, revamped website. The Discussion Forum is for everyone whose life has been touched in any way by cholangiocarcinoma (bile duct cancer, biliary tract cancer, gall bladder cancer) providing an area where patients, family members, carers, supporters, fundraisers and those who have been bereaved, can talk about all things related t...

Read More

AMMF’s Information Day 2016, Imperial College London

This year's AMMF Information Day will take place on Tuesday, 10th May, at Imperial College London. There will speakers from different areas of research around the UK that AMMF is supporting, presenting their work and being available to meet and talk with the charity’s fundraisers and supporters.  Plus, there will be an 'Ask the Expert' panel with specialists in the field of cholangiocarcinoma, re...

Read More

CC Awareness Month 2016 Guest Posts

Thank you to each courageous person who contributed a Guest Post for AMMF's Facebook page during Cholangiocarcinoma Awareness Month, February 2016. We know that each of these posts is a personal story, with every word written from the heart - which is exactly what makes them so very special. This year, the number of likes, shares and supportive comments each Guest Post received was beyond anything we ...

Read More

“Progress with targeted agents in cholangiocarcinoma – reality or myth?”

At the ESMO1 17th World Congress on Gastrointestinal Cancer held in Barcelona in July 2015, Professor Juan Valle, consultant and medical oncologist at The Christie, Manchester UK, and one of AMMF’s medical advisors, spoke about the progress being made in the understanding of cholangiocarcinoma, the studies being carried out to find target agents, and also genomic profiling, in the search for better and mo...

Read More

GWAS Cholangiocarcinoma Study

The Genome-wide Association Study (GWAS) for Cholangiocarcinoma Professor Simon Taylor-Robinson and Dr. Shahid Khan at Imperial College London are collaborating on the GWAS project with the Mayo clinic in the USA1, as one of their ongoing studies in cholangiocarcinoma. If you2 would be interested in donating blood and urine samples for analysis to the Imperial Hepatology & Gastroenterology BioBank...

Read More

The ABC-03 trial

As a result of the landmark ABC-02 study, the Cisplatin and Gemcitabine chemotherapy combination1 is recognised as the standard first-line treatment for those with inoperable biliary tract cancer (cholangiocarcinoma).  However, the search goes on for improvements to this regime. In the ABC-03 study, Cediranib (an anti angiogenic drug1) was added to the Gemcitabine / Cisplatin combination. Unfortu...

Read More

Interim Report from AMMF’s Research Fellow

AMMF has just received an interim report from the Institute of Hepatology in London on the cholangiocarcinoma research work being carried out there by our Research Fellow, Dr Gemma Choy. This work has involved investigating whether the MAPK signalling pathway allows intrahepatic cholangiocarcinoma cell proliferation.  We are very pleased to learn that the project is progressing well with results to ...

Read More